Dow Up 0.11% Nasdaq Up 0.50%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
15.91 0.17(1.08%) Aug 29, 4:00PM EDT
Prev Close:15.74
Open:15.87
Bid:15.29 x 200
Ask:16.50 x 1000
1y Target Est:36.50
Beta:3.32
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:15.78 - 16.23
52wk Range:10.76 - 38.84
Volume:1,308,004
Avg Vol (3m):2,490,040
Market Cap:1.42B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXUp 1.08%1.42B
DNDN211.38M
LLY68.12B
RHHBY248.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):539.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.31
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback